H.R.7839: Continuing Access to In-Home IVIG Act

About This Bill

Bill Version

Bill Summary

Continuing Access to In-Home IVIG Act This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.7839.

Bill Actions

Date Description
July 29, 2020
Referred to the Subcommittee on Health.
July 29, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
July 29, 2020

Introduced in the House by Doris Matsui (D-Calif.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page